MedPath

Consumption of Chocolate in Pregnant Women.

Phase 2
Completed
Conditions
Preeclampsia
Interventions
Other: Placebo Chocolate
Other: Flavanol-rich chocolate
Registration Number
NCT01431443
Lead Sponsor
Laval University
Brief Summary

The purpose of this study is to investigate the acute and chronic effect of consumption of flavanol-rich chocolate on endothelium function in pregnant women at high risk for preeclampsia.

Detailed Description

Although numerous strategies have been studied, no effective prevention or treatment of preeclampsia is yet available for pregnant women. This is surprising considering the growing body of literature that supports the hypothesis of a beneficial effect of dark chocolate consumption through the activity of flavanols on the endothelial function and blood pressure regulation, to find any clinical data among pregnant women with preeclampsia.

The primary objective of the trial is to investigate the acute and chronic effect of consumption of flavanol-rich chocolate on endothelial function in pregnant women at high risk of preeclampsia. This 12-week efficacy study will permit us to verify the sustainability of the effect of daily intake of flavanol-rich chocolate intake.

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
160
Inclusion Criteria
  • Pregnant women between the ages of 18 and 40 years.
  • Presence of uterine diastolic notches measured by uterine artery Doppler between 10 and 14 weeks.
Exclusion Criteria
  • Hypertension requiring medication.
  • Currently or previously use of medications interfering with glucose or lipids metabolism.
  • Use of supplements or natural health products that interfere with blood pressure.
  • Consumption of 1 or more alcohol drink per day.
  • Allergy or intolerance to nuts or chocolate.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Placebo chocolatePlacebo ChocolatePlacebo intervention
Dark chocolateFlavanol-rich chocolate-
Primary Outcome Measures
NameTimeMethod
Changes in endothelial functionwithin the first 12 weeks of chocolate intake
Secondary Outcome Measures
NameTimeMethod
Doppler of uterine arterieswithin the first 12 weeks of chocolate intake
Blood pressurewithin the first 12 weeks of chocolate intake
Plasma biomarker of endothelium functionwithin the first 12 weeks of chocolate intake
Plasma biomarker of chocolate intakewithin the first 12 weeks of chocolate intake

ng\\ml plasma

Trial Locations

Locations (1)

Laval University, Department of Medicine, Institut des nutraceutiques et des aliments fonctionnels.

🇨🇦

Québec, Quebec, Canada

© Copyright 2025. All Rights Reserved by MedPath